A new experimental drug may offer hope for pancreatic cancer patients. One of deadliest types of cancer in the United States, an estimated 52,740 Americans will die from the disease this year, ...

Data from a major breakthrough in the fight against pancreatic cancer was released this month, highlighting a new pill that targets the root cause of how the disease exists and spreads. Arizona ...

For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...

It’s not often that you see a standing ovation at a medical conference. But over the weekend, a ballroom full of cancer specialists got to their feet to applaud a slide showing that Revolution ...

A medical breakthrough in the fight against pancreatic cancer is showing promising results after decades of research. The experimental drug, taken once a day, extends patients’ lives by slowing the ...

An experimental drug nearly doubled the overall survival rates of pancreatic cancer patients, according to the results of its latest clinical trial. The drug, daraxonrasib, targets the gene mutation ...

CHICAGO, May 31 (Reuters) - Revolution Medicine's (RVMD.O), opens new tab experimental pancreatic cancer pill doubled survival compared with chemotherapy and improved symptoms enough that some ...

A pancreatic cancer drug more than four decades in the making has cracked one of the most stubbornly lethal cancers, extending people’s lives and keeping their tumors in check for twice as long as ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer. “While not ...

A virus has stopped pancreatic cancer in its tracks in three people in a clinical trial in the US. Further evaluation is needed in larger trials, but the early results are encouraging, especially ...

For decades, one of the deadliest cancers had an Achilles’ heel lying in plain sight. Pancreatic cancer is an exquisitely cruel diagnosis, leaving only 13 percent of people alive after five years. But ...

The new oral medication, daraxonrasib, has been shown to meaningfully extend the lives of patients with late-stage pancreatic cancer Getty Daraxonrasib targets a previously untreatable protein in ...